Boothbay Fund Management’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $810K | Buy |
|
|||||
|
2025
Q1 | $566K | Hold |
|
|||||
|
2024
Q4 | $531K | Sell |
|
|||||
|
2024
Q3 | $2.36M | Hold |
|
|||||
|
2024
Q2 | $1.89M | Hold |
|
|||||
|
2024
Q1 | $1.58M | Buy |
|
|||||
|
2023
Q4 | $1.13M | Sell |
|
|||||
|
2023
Q3 | $998K | Hold |
|
|||||
|
2023
Q2 | $1.13M | Sell |
|
|||||
|
2023
Q1 | $1.89M | Sell |
|
|||||
|
2022
Q4 | $1.66M | Sell |
|
|||||
|
2022
Q3 | $1.47M | Buy |
|
|||||
|
2022
Q2 | $1.5M | Buy |
|
|||||
|
2022
Q1 | $1.46M | Buy |
|
|||||
|
2021
Q4 | $1.78M | Buy |
|
|||||
|
2021
Q3 | $686K | Buy |
|
|||||
|
2021
Q2 | $182K | Buy |
|
|||||
|
2021
Q1 | $144K | Sell |
|
|||||
|
2020
Q4 | $168K | Buy |
|
|||||
|
2020
Q3 | $41K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $59K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $350K | Buy |
|